JW-1521

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameJW-1521
Drug Alias NameCG-1521
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCircaGen Pharmaceutical Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSan Rocco Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A